Conversation on Microdosing

Join us on November 12th for an insightful evening at the Athenaeum in Midtown Manhattan, hosted by the Psychedelic Assembly, featuring C.J. Spotswood, MSN, APRN, PMHNP-BC, also known as "EntheoNurse."

C.J., a board-certified psychiatric-mental health nurse practitioner and author of The Microdosing Guidebook, will be in conversation with Court Wing, founder of REMAP Therapeutics and co-founder of the Psychedelics & Pain Association (PPA)

This discussion will delve into the science and practice of microdosing, its distinctions from traditional antidepressants, and the emerging research surrounding its potential benefits for mental and physical health. C.J. will also share practical guidance on microdosing, alongside an exploration of the challenges and ethical considerations facing this growing field. Whether you're new to the concept or an experienced advocate, this talk will provide a comprehensive overview of the current landscape in psychedelic medicine.

Copies of "The Microdosing Guidebook" will be for sale, and available to be signed after the event.

C.J. Spotswood, MSN, APRN, PMHNP-BC aka “EntheoNurse” is a board-certified

psychiatric-mental health nurse practitioner with his practice in central Maine. C.J. is a

3rd-generation male nurse and has over 20 years of psychiatric nursing experience.

C.J. is the author of The Microdosing Guidebook: A Step-by-Step Manual to Improve

Your Physical and Mental Health through Psychedelic Medicine, published by Ulysses

Press.

C.J. is a graduate of the University of Southern Maine, completing his masters as a

Psychiatric Mental Health Nurse Practitioner. Prior, C.J.’s undergraduate nursing

degree (BSN) was from the University of Maine at Augusta, one of 15 nursing schools

endorsed as a holistic school of nursing. This curriculum included yoga, Reiki, and

various other complementary and alternative modalities. C.J. is past graduate of

Psychedelics Today’s Navigating Psychedelics for Clinicians and Therapists program

and graduate of the California Institute of Integral Studies’ (CIIS) Psychedelic-Assisted

Therapies and Research (CPRT) certificate program in their Boston cohort. C.J. is also

the principal psychiatric clinician for REMAP therapeutics, working with psychedelics for

individuals with chronic pain and earlier this year published “Refractory CRPS Pain

Treated with Psilocybin: A Case Report” earlier this year.

C.J. has been researching and educating on psychedelics since 2018, having presented

both nationally and internationally including; the American Psychiatric Nurse

Association’s (APNA) National Conference on the topic of psychedelics in psychiatry,

teaching master classes for Psychedelics Today’s Navigating Psychedelics: Clinicians &

Therapists education program and their year long Vital Psychedelics Education

Program, co-authored Psychedelic.Support’s 9-hour CME accredited education

program entitled “Understanding Psilocybin: Effects, Neurobiology, and Therapeutic

Approaches”, and author of the “Psychedelics in Psychiatry, the Nursing Influence, and

the Future of Psychedelic Therapies” which was recently published in the Journal of the

American Psychiatric Nurses Association (JAPNA). C.J. is also active with various

organizations including; OPENurses (Organization of Psychedelic and Entheogenic

Nurses), the Psychedelic Medicine Association, Reconsider.org, and the Psychedelics

and Pain Association. When he is not working, reading, or writing, C.J. can be found

spending time with his daughter, Malarie, exploring Maine’s outdoors and craft

breweries.

Entheonurse.com

FB: Entheonurse

IG: The_Entheonurse

A former chronic pain sufferer, Court Wing is the founder and CEO of REMAP Therapeutics and a co-founder of the Psychedelics & Pain Association. REMAP Therapeutics is devoted to the development of formal psychedelic rehabilitation sessions and cohesive best practices for many treatment-resistant chronic pain conditions.

Court is an accomplished performance and pain professional with 30 years of experience in maximizing the athletic performance of his clients, helping countless individuals overcome injuries to return to competition and daily life. He is a certified Z-Health Master Trainer, was co-founder of NYC:S first CrossFit and is formally trained in Ki-Aikido.

In 2020, Court was a study participant in NYU’s clinical trial of Psilocybin for major depressive disorder. By the end of his “dosing” day in the trial, he was in full remission, no longer qualifying for the diagnosis of depression. More astonishly were the lateral benefits; he was also no longer suffering from low-to-moderate chronic pain and related neurological issues from previous injuries. Court’s commitment to further investigate the healing potential of psychedelics stems from his direct experience as a participant in this psilocybin trial. With his extensive experience in applied neurophysiology for pain and performance, he immediately realized psychedelics were going to completely change the way we are able to treat chronic pain.

Host or Publisher The Psychedelic Assembly